MoneyWorks4Me

Vivimed Labs informs about financial results

31 May 2016 Evaluate

With Reference to the earlier announcement dated May 30, 2016, regarding Financial Results for March 31, 2016 Vivimed Labs has informed that there is a type error in the Consolidated Segment Results and Segment Wise Consolidated Capital Employed mentioned in the column for quarter ended December 31, 2015. Now the Company has submitted a copy of the corrected copy of the Segment-Wise Consolidated Financial Results and Capital Employed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..